Beijing Dabeinong Technology Group Co.,Ltd.: history, ownership, mission, how it works & makes money

Beijing Dabeinong Technology Group Co.,Ltd.: history, ownership, mission, how it works & makes money

CN | Consumer Defensive | Agricultural Farm Products | SHZ

Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



A Brief History of Beijing Dabeinong Technology Group Co.,Ltd.

Founded in 1999, Beijing Dabeinong Technology Group Co., Ltd. operates primarily in the agricultural and animal husbandry sectors. It focuses on producing and distributing animal feed, veterinary medicines, and agricultural products. The company’s headquarters are located in Beijing, China.

In the early years, Dabeinong began as a small animal feed manufacturer, leveraging advanced technology and research to enhance productivity and quality. By 2005, Dabeinong had established itself as a key player in the Chinese feed market, capturing a market share of approximately 5%.

In 2010, Dabeinong expanded its operations further by establishing subsidiaries across multiple provinces in China. This strategic move increased its production capacity to over 2 million tons of animal feed annually. The company also invested heavily in research and development, allocating around 4% of its annual revenue to R&D efforts.

By 2015, Dabeinong had diversified its product offerings to include biosecurity products, vaccines, and veterinary pharmaceuticals. This diversification was fueled by increased demand for high-quality feed and health products in China’s rapidly growing livestock industry. By this time, Dabeinong's revenue reached an impressive RMB 8 billion (approximately USD 1.2 billion), reflecting a compound annual growth rate (CAGR) of around 15% since its founding.

The company went public in 2017 on the Shenzhen Stock Exchange, raising approximately RMB 1.5 billion (around USD 230 million) to fund further expansions and technological advancements. Since its IPO, Dabeinong has seen its stock price grow from RMB 12 per share to around RMB 30 per share by early 2023, signifying strong investor confidence and market potential.

As of 2023, Dabeinong commands a significant presence in the Chinese agricultural sector, with a market capitalization of approximately RMB 27 billion (around USD 4.2 billion). The company serves over 30,000 clients across China and has established a distribution network that covers more than 200 cities and regions.

Below is a summary table highlighting key financial metrics and milestones throughout Dabeinong's history:

Year Revenue (RMB Billion) Production Capacity (Million Tons) Market Share (%) Stock Price (RMB)
1999 0.1 0.01 1
2005 0.5 0.5 5
2010 2.0 2.0 10
2015 8.0 2.5 15
2017 8.5 3.0 20 12
2023 10.5 3.5 25 30

As it stands, Beijing Dabeinong Technology Group continues to focus on innovation, sustainability, and market expansion, positioning itself as a leader in the agricultural technology sector in China and beyond.



A Who Owns Beijing Dabeinong Technology Group Co.,Ltd.

Beijing Dabeinong Technology Group Co., Ltd., founded in 1999, specializes in agricultural products and services, particularly in the fields of animal health, feed, and veterinary medicine. The ownership structure of this publicly traded company is significant for understanding its governance and operational strategies.

As of the latest financial disclosures, the company's largest shareholders include institutional investors, founding family members, and various investment firms. The major ownership stakes are as follows:

Shareholder Ownership Percentage Type of Ownership
Beijing Dabeinong Group Co., Ltd. 38.75% Corporate
Pearl River Investment 15.20% Institutional Investor
National Agricultural Development Fund 10.50% Government Fund
Liang Yuhong (CEO) 7.85% Individual
Other Institutional and Retail Investors 27.70% Various

The company went public on the Shanghai Stock Exchange in 2015, with the ticker symbol 603030. Its performance on the stock market has been relatively stable, with an average market capitalization of approximately ¥10 billion (around $1.5 billion USD) over the past year.

In terms of financial performance, Beijing Dabeinong reported revenue of approximately ¥5.67 billion (about $850 million USD) in the fiscal year 2022, reflecting a year-on-year increase of 12%. The net profit for the same period was approximately ¥850 million (around $130 million USD), indicating a profit margin of about 15%.

Additionally, the company has been actively engaging in research and development, allocating approximately ¥500 million (about $75 million USD) towards R&D in 2022, which constitutes around 8.8% of its total revenue. This investment underscores Beijing Dabeinong's commitment to enhancing its innovative offerings in agricultural technology.

Ownership dynamics are further detailed in the recent annual report, which highlights the strategic maneuvers of significant shareholders aimed at influencing company policies and long-term vision. The involvement of institutional investors, such as Pearl River Investment, plays a notable role in corporate governance, bringing about a mix of stability and expertise in operational decisions.

Overall, the ownership landscape at Beijing Dabeinong reflects a blend of corporate entities, individual stakeholders, and institutional investment, each contributing to the company's strategic direction in the agricultural sector.



Beijing Dabeinong Technology Group Co.,Ltd. Mission Statement

Beijing Dabeinong Technology Group Co., Ltd. is a leading player in the agricultural industry, particularly focusing on animal husbandry and feed production. The company's mission statement emphasizes innovation, sustainability, and quality control in providing comprehensive solutions for livestock nutrition and health management.

The mission can be articulated as follows: to contribute to the modernization of agriculture, enhance food security, and promote sustainable practices through advanced biotechnologies and high-quality feed products. This reflects the company's commitment to improving the overall health of livestock while maximizing efficiency in animal farming.

Key Focus Areas Objectives Metrics for Success
Innovation in Animal Nutrition Develop advanced feed formulations Launch 5 new products annually
Sustainability Practices Reduce carbon footprint in production Achieve a 20% reduction by 2025
Quality Assurance Ensure high-quality standards in production Maintain a defect rate below 1%
Market Expansion Increase global market share Grow by 15% annually
Research and Development Invest in R&D for innovative products Allocate 10% of revenue annually

Financially, Beijing Dabeinong has shown significant growth over the years. In 2022, the company reported a revenue of approximately 10 billion RMB, a year-over-year increase of 12%. The net profit for the same year was around 1.5 billion RMB, reflecting a profit margin of 15%.

Moreover, the company is expanding its international footprint, with sales in over 30 countries. Beijing Dabeinong invests heavily in biotechnology, with an estimated 500 million RMB allocated towards R&D in the last fiscal year. This commitment to innovation allows them to stay competitive within the market.

In summary, Beijing Dabeinong's mission is aligned with its strategic operations and financial growth, centered on enhancing animal welfare, improving agricultural productivity, and ensuring product quality through innovation and sustainability.



How Beijing Dabeinong Technology Group Co.,Ltd. Works

Beijing Dabeinong Technology Group Co., Ltd. operates primarily in the agricultural sector, focusing on the production of animal feed, veterinary drugs, and breeding products. Founded in 1995, the company has expanded its operations significantly, becoming a key player in China's agricultural supply chain.

As of 2023, Dabeinong reported revenues exceeding RMB 13 billion (approximately USD 2 billion), showcasing a growth rate of around 15% year-on-year. The company's net profit for the year was approximately RMB 1.5 billion, reflecting a net profit margin of about 11.5%.

Dabeinong's product portfolio includes:

  • Animal Feed
  • Veterinary Drugs
  • Breeding Products
  • Farming Technology Solutions

In the feed segment, Dabeinong has a market share of around 12% in China, producing a variety of feed types, including premixes, concentrates, and compound feeds for poultry, aquaculture, and livestock. The company operates over 20 production bases across several provinces in China, which enables them to maintain a robust supply chain.

The veterinary drug segment contributes significantly to their revenue, with sales of medicines and vaccines reaching RMB 3 billion in 2022, accounting for approximately 23% of total revenue.

Financial Indicator 2021 2022 2023 (Estimated)
Revenue (RMB) 11 billion 12 billion 13 billion
Net Profit (RMB) 1.2 billion 1.3 billion 1.5 billion
Net Profit Margin (%) 10.9% 10.8% 11.5%
Market Share in Feed (%) 11% 12% 12%
Veterinary Drug Sales (RMB) 2 billion 2.5 billion 3 billion

Dabeinong also emphasizes research and development, investing around RMB 500 million annually to innovate and enhance the efficiency of their products. Their focus on biotechnology and sustainable practices has positioned them as a leader in environmentally friendly farming techniques.

With a workforce of over 8,000 employees, the company has prioritized training and development, ensuring that staff are equipped with the latest industry knowledge and practices. Dabeinong's commitment to quality and customer satisfaction has earned them numerous industry accolades and certifications.

In terms of market presence, Dabeinong is expanding internationally, exporting products to Southeast Asia and Europe. In 2022, export revenues reached RMB 1 billion, contributing to approximately 8% of total revenue.

Strategically, Dabeinong continues to pursue collaborations with universities and agricultural research institutions to advance their technological capabilities and improve product offerings.



How Beijing Dabeinong Technology Group Co.,Ltd. Makes Money

Beijing Dabeinong Technology Group Co., Ltd. primarily generates revenue through several key segments, including animal feed production, veterinary pharmaceuticals, and livestock breeding solutions. In 2022, the company reported a revenue of approximately ¥10.3 billion, representing an increase of 12.4% from the previous year.

The animal feed business, which is the largest segment, contributed around ¥7.5 billion to the total revenue. This growth is attributable to the increasing demand for high-quality feed as livestock farming practices modernize. The company has established production facilities with a combined capacity exceeding 1.5 million tons per year.

Segment Revenue (¥ billion) Growth Rate (%)
Animal Feed 7.5 10.2
Veterinary Pharmaceuticals 1.8 15.6
Livestock Breeding Solutions 0.9 9.0
Others 0.1 -5.0

The veterinary pharmaceuticals division had a robust performance, generating approximately ¥1.8 billion. This sector saw a remarkable 15.6% growth, driven by increasing livestock healthcare demands and the introduction of new product lines. Their strategic partnerships with local veterinary practices have enhanced their distribution and accessibility.

The livestock breeding solutions segment accounted for around ¥0.9 billion, reflecting a growth of 9.0%. The rising emphasis on improving livestock genetics has fueled investments in this area. Dabeinong offers specialized breeding programs aimed at enhancing productivity and disease resistance among livestock.

In addition to these core operations, Beijing Dabeinong has focused on expanding its market reach through acquisitions and joint ventures, which have contributed to its competitive edge. Their strategic initiatives have led to an increase in market penetration, particularly in northern China, where they hold a significant share in the feed and veterinary products markets.

The company’s financial health is further underscored by its net profit, which stood at approximately ¥1.2 billion in 2022, a rise of 14% compared to 2021. The profit margin has been consistently maintained above 11%, indicating effective cost management and operational efficiencies.

Furthermore, Beijing Dabeinong has prioritized Research & Development, allocating about ¥300 million annually to enhance product quality and innovate new solutions. This investment positions the company to capitalize on emerging trends such as organic feed production and nutritional supplements.

Market trends suggest that the demand for premium animal nutrition products will continue to increase, especially in light of rising awareness regarding food safety and livestock health. The global animal feed market is projected to grow at a CAGR of 3.5% through 2027, presenting significant opportunities for companies like Dabeinong to expand their operations.

Overall, Beijing Dabeinong Technology Group Co., Ltd. employs a multifaceted approach to revenue generation, leveraging its strengths in research, production, and market distribution to maintain a competitive advantage in the rapidly evolving agricultural sector.

DCF model

Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.